chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood sodium increased, Bradycardia, Brain natriuretic peptide increased
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac failure acute, Condition aggravated, Device failure, Diuretic therapy
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Electrocardiogram normal, Fall, Hypernatraemia
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Hypovolaemia, Illness, Injury, Intensive care, Left ventricular failure
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Liver function test increased, Malnutrition, Myocardial ischaemia, Oedema peripheral, Platelet count decreased
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Sinus rhythm, Thrombocytopenia, Troponin increased
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Wall motion score index abnormal
Clinical narrative: Patient is a 88 y.o. male with a history of atrial fibrillation (not on AC), HFpEF, HTN who presented to RMH 8/28/2023 with shortness of breath. Found to have acute hypoxic respiratory failure due to COVID-19 and placed on BiPAP and admitted to the ICU. Course complicated by slow improvement. Consulted for transfer of care.    1. Acute hypoxic respiratory failure: not on O2 at baseline. Required BiPAP/HHFNC on admit. Due to COVID-19. S/p ceftriaxone for possible superimposed bacterial pneumonia (last dose 9/3/23). Weaned to NC by 8/30/23, RA on 9/6/23. Pulmonary hygiene. 2. Severe COVID-19: tested positive 8/28/23. Continued dexamethasone (end 9/6/23) and remdesivir (end 9/1/23). 3. Elevated troponin: admit EKG non-acute. TTE 8/28/23 showed new septal WMA, which is mild and not significant per cardiology. Suspect demand ischemia. S/p heparin gtt. Continued home ASA; initiated statin. Cardio recommended outpatient follow-up for repeat echo/stress test once acute illness resolved.  4. Acute on chronic HFpEF: TTE 8/28/23 as above. BNP on admit elevated. Continue spot IV diuresis as able. Cardio followed. 5. Hypernatremia: suspect hypovolemic. Na 150 on 8/31/23. Held further diuresis and started gentle IVFs 8/31/23. Resolved.  6. Paroxysmal atrial fibrillation: was off of AC due to frequent falls. Watchman was attempted but unsuccessful. ECG on admit NSR. Cardio recommended revisiting AC vs LAA closure as outpatient. 7. Acute RLE edema: LEVD on admit negative for DVT. Suspect related to trauma. Supportive care.  8. Elevated LFTs: admit AST 47, ALT 42, ALP wnl, T bili wnl. Suspect due to COVID-19. Improving. 9. Chronic Thrombocytopenia: baseline Plt ~80; stable. Trend. 10. HTN: home meds held on admit; resumed slowly. Inderal reduced due to bradycardia. Titrate meds prn.  11. CAD: s/p PCI to the LAD in 2004. Continued med mgmt.  12. Moderate Malnutrition: POA. Dietician followed.  13. Code status: Full, confirmed with patient and wife 9/5
Age: 77.0
Sex: M
Vaccine: RSV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: RED BUMP AND SWOLLEN FOR 1 WEEK AT INJECTION SITE
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eyelid infection, Hordeolum
Clinical narrative: I have an infected stye - that came the day after the shot.  It may likely have been caused by the shot - so my doc wanted me to report it.  It may also be a coincidence, but that is most unlikely.
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Fatigue
Clinical narrative: extreme fatigue and diarrhea for days
Age: 0.83
Sex: M
Vaccine: FLU4
Symptoms: Rash, Skin irritation
Clinical narrative: Vaccine received 9/30/23 11:00am, symptoms started 9/30/23 at 16:00: rash and skin irritation on face/neck
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site irritation, Injection site pruritus, Injection site rash, Injection site reaction
Clinical narrative: Allergic reaction at the injection site.  Rash, itching, red, irritated skin warmer to the touch on and around injection site.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site warmth
Clinical narrative: Allergic reaction at the injection site.  Rash, itching, red, irritated skin warmer to the touch on and around injection site.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture negative, C-reactive protein, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient is a 56 year old female patient with a past medical history of hypothyroidism, gout, allergic rhinitis, ADHD, depression who presented to ED 8/27/2023 with complaints of COVID-19 exposure, fever, cough, shortness of breath, nausea/vomiting.  Tested positive for COVID-19.  Admitted for further workup/management.  Course is remarkable for:   COVID-19 virus infection Pneumonia due to COVID-19 CXR on admission showed suspected minimal infiltrate in RLL Since she is having pleuritic discomfort and D dimer is positive CT pulmonary arteries-no evidence of PE Continue IV Decadron Continue remdesivir 5 days Albuterol as needed, antitussive as needed Tylenol for pain and fever. blood cultures NGTD ESR CRP trending down Ferritin trending down   Depression Continue citalopram   Hypothyroidism Continue levothyroxine   GERD Continue PPI
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Computerised tomogram thorax normal, Cough, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: Patient is a 56 year old female patient with a past medical history of hypothyroidism, gout, allergic rhinitis, ADHD, depression who presented to ED 8/27/2023 with complaints of COVID-19 exposure, fever, cough, shortness of breath, nausea/vomiting.  Tested positive for COVID-19.  Admitted for further workup/management.  Course is remarkable for:   COVID-19 virus infection Pneumonia due to COVID-19 CXR on admission showed suspected minimal infiltrate in RLL Since she is having pleuritic discomfort and D dimer is positive CT pulmonary arteries-no evidence of PE Continue IV Decadron Continue remdesivir 5 days Albuterol as needed, antitussive as needed Tylenol for pain and fever. blood cultures NGTD ESR CRP trending down Ferritin trending down   Depression Continue citalopram   Hypothyroidism Continue levothyroxine   GERD Continue PPI
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Gastrooesophageal reflux disease, Lung infiltration, Nausea, Pain
Clinical narrative: Patient is a 56 year old female patient with a past medical history of hypothyroidism, gout, allergic rhinitis, ADHD, depression who presented to ED 8/27/2023 with complaints of COVID-19 exposure, fever, cough, shortness of breath, nausea/vomiting.  Tested positive for COVID-19.  Admitted for further workup/management.  Course is remarkable for:   COVID-19 virus infection Pneumonia due to COVID-19 CXR on admission showed suspected minimal infiltrate in RLL Since she is having pleuritic discomfort and D dimer is positive CT pulmonary arteries-no evidence of PE Continue IV Decadron Continue remdesivir 5 days Albuterol as needed, antitussive as needed Tylenol for pain and fever. blood cultures NGTD ESR CRP trending down Ferritin trending down   Depression Continue citalopram   Hypothyroidism Continue levothyroxine   GERD Continue PPI
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate, SARS-CoV-2 test positive, Serum ferritin, Vomiting
Clinical narrative: Patient is a 56 year old female patient with a past medical history of hypothyroidism, gout, allergic rhinitis, ADHD, depression who presented to ED 8/27/2023 with complaints of COVID-19 exposure, fever, cough, shortness of breath, nausea/vomiting.  Tested positive for COVID-19.  Admitted for further workup/management.  Course is remarkable for:   COVID-19 virus infection Pneumonia due to COVID-19 CXR on admission showed suspected minimal infiltrate in RLL Since she is having pleuritic discomfort and D dimer is positive CT pulmonary arteries-no evidence of PE Continue IV Decadron Continue remdesivir 5 days Albuterol as needed, antitussive as needed Tylenol for pain and fever. blood cultures NGTD ESR CRP trending down Ferritin trending down   Depression Continue citalopram   Hypothyroidism Continue levothyroxine   GERD Continue PPI
Age: 81.0
Sex: F
Vaccine: FLUA4
Symptoms: Muscle tightness, Neck pain, Pain in extremity
Clinical narrative: pain in arm from elbow up, pain in neck similar to a tight neck muscle
Age: 37.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Treponema test false positive
Clinical narrative: Repeatedly False Positive  for TP-PA
Age: 61.0
Sex: F
Vaccine: RSV
Symptoms: Electric shock sensation, Fear, Headache, Lymphadenopathy, Pain
Clinical narrative: Severe arm pain, dizziness symptoms started same day of vaccine and severe vertigo and whole-body achiness on day two. The vertigo continues with sudden sharp pains in my head. They feel almost like an electric shock comes out of nowhere at the top of my right side of brain. It is very frightening especially when driving when this happens. Sharp pain happens more when I am lying in bed look to right or look up. I have also had swollen lymph nodes under arms and breast areas since vaccine.
Age: 61.0
Sex: F
Vaccine: RSV
Symptoms: Pain in extremity, Vertigo
Clinical narrative: Severe arm pain, dizziness symptoms started same day of vaccine and severe vertigo and whole-body achiness on day two. The vertigo continues with sudden sharp pains in my head. They feel almost like an electric shock comes out of nowhere at the top of my right side of brain. It is very frightening especially when driving when this happens. Sharp pain happens more when I am lying in bed look to right or look up. I have also had swollen lymph nodes under arms and breast areas since vaccine.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Vaccination site swelling
Clinical narrative: Swelling and redness to the left arm below vaccination administered site.
Age: 98.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Death
Clinical narrative: Patient expired 9/30/2023.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Blood creatinine increased, Bronchial wall thickening, COVID-19
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with back pain, weakness, found to have covid. Initially not on oxygen and family requested paxlovid which was started. Did require 1-2L NC with some wheezing on exam, started steroids with good response, able to wean off oxygen. Symptoms all improving. Family requested SNF on DC.    COVID-19 Generalized Weakness -Presented with: Weakness, back pain, increased cough. -Symptom onset: 9/11 per family (cough increased at that time) -Positive COVID-19: 9/11 at Hospital -Vaccination status: Vaccinated with Moderna and boosted with Pfizer with booster dose on 10/2022 -CXR on admission showed mild peribronchial thickening with no discrete infiltrates. -Oxygen status: up to 2L NC-> RA 9/14, started dexamethasone 9/13. Started paxlovid 9/12 when she was off O2, given this is a targeted treatment for covid / likely more beneficial than remdesivir, will continue paxlovid, off O2 on 9/14/23 -Serial COVID labs ordered: No -Case Management/Social Services consulted: Yes -Consulted PT and OT   Back pain, seemingly resolved -started mid last week, mainly right scapula per family, but now farther down back.  -+MSK TTP of back from lower cervical spine to mid thoracic, likely MSK in etiology -tylenol prn. PT/OT   Dementia -This is a known historical diagnosis. -Patient takes donepezil 10 mg nightly and memantine 1 -Continue home medications with formulary change to memantine. -Delirium precautions. CKD3A -Baseline creatinine of 1.3?1.4, confirmed with outpatient records. -Patient is currently at baseline. -at home on Macrobid, this was prescribed to her by her urologist and the patient has had good control of her UTIs as without that she has had significant issues with UTIs.  Appears the patient has had any side effects per discussion with the daughter given her decreased GFR at baseline. Plan to resume on dc   Chronic cough -Etiology unclear. Stopped lisinopril in the past without any benefit -Patient is on Flonase in the outpatient setting.  Also takes Tessalon Perles. -Continue Tessalon Perles continue to monitor.   HTN -Continue home lisinopril.   History of recurrent UTIs -Seen by outpatient urology.  Sees Dr.  -Last evaluated 10/2022. -She was placed on Macrobid for recurrent UTIs and has had good symptomatic control.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chest pain, Chronic kidney disease, Cough, Glomerular filtration rate decreased
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with back pain, weakness, found to have covid. Initially not on oxygen and family requested paxlovid which was started. Did require 1-2L NC with some wheezing on exam, started steroids with good response, able to wean off oxygen. Symptoms all improving. Family requested SNF on DC.    COVID-19 Generalized Weakness -Presented with: Weakness, back pain, increased cough. -Symptom onset: 9/11 per family (cough increased at that time) -Positive COVID-19: 9/11 at Hospital -Vaccination status: Vaccinated with Moderna and boosted with Pfizer with booster dose on 10/2022 -CXR on admission showed mild peribronchial thickening with no discrete infiltrates. -Oxygen status: up to 2L NC-> RA 9/14, started dexamethasone 9/13. Started paxlovid 9/12 when she was off O2, given this is a targeted treatment for covid / likely more beneficial than remdesivir, will continue paxlovid, off O2 on 9/14/23 -Serial COVID labs ordered: No -Case Management/Social Services consulted: Yes -Consulted PT and OT   Back pain, seemingly resolved -started mid last week, mainly right scapula per family, but now farther down back.  -+MSK TTP of back from lower cervical spine to mid thoracic, likely MSK in etiology -tylenol prn. PT/OT   Dementia -This is a known historical diagnosis. -Patient takes donepezil 10 mg nightly and memantine 1 -Continue home medications with formulary change to memantine. -Delirium precautions. CKD3A -Baseline creatinine of 1.3?1.4, confirmed with outpatient records. -Patient is currently at baseline. -at home on Macrobid, this was prescribed to her by her urologist and the patient has had good control of her UTIs as without that she has had significant issues with UTIs.  Appears the patient has had any side effects per discussion with the daughter given her decreased GFR at baseline. Plan to resume on dc   Chronic cough -Etiology unclear. Stopped lisinopril in the past without any benefit -Patient is on Flonase in the outpatient setting.  Also takes Tessalon Perles. -Continue Tessalon Perles continue to monitor.   HTN -Continue home lisinopril.   History of recurrent UTIs -Seen by outpatient urology.  Sees Dr.  -Last evaluated 10/2022. -She was placed on Macrobid for recurrent UTIs and has had good symptomatic control.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Musculoskeletal pain, Spinal pain, Wheezing
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with back pain, weakness, found to have covid. Initially not on oxygen and family requested paxlovid which was started. Did require 1-2L NC with some wheezing on exam, started steroids with good response, able to wean off oxygen. Symptoms all improving. Family requested SNF on DC.    COVID-19 Generalized Weakness -Presented with: Weakness, back pain, increased cough. -Symptom onset: 9/11 per family (cough increased at that time) -Positive COVID-19: 9/11 at Hospital -Vaccination status: Vaccinated with Moderna and boosted with Pfizer with booster dose on 10/2022 -CXR on admission showed mild peribronchial thickening with no discrete infiltrates. -Oxygen status: up to 2L NC-> RA 9/14, started dexamethasone 9/13. Started paxlovid 9/12 when she was off O2, given this is a targeted treatment for covid / likely more beneficial than remdesivir, will continue paxlovid, off O2 on 9/14/23 -Serial COVID labs ordered: No -Case Management/Social Services consulted: Yes -Consulted PT and OT   Back pain, seemingly resolved -started mid last week, mainly right scapula per family, but now farther down back.  -+MSK TTP of back from lower cervical spine to mid thoracic, likely MSK in etiology -tylenol prn. PT/OT   Dementia -This is a known historical diagnosis. -Patient takes donepezil 10 mg nightly and memantine 1 -Continue home medications with formulary change to memantine. -Delirium precautions. CKD3A -Baseline creatinine of 1.3?1.4, confirmed with outpatient records. -Patient is currently at baseline. -at home on Macrobid, this was prescribed to her by her urologist and the patient has had good control of her UTIs as without that she has had significant issues with UTIs.  Appears the patient has had any side effects per discussion with the daughter given her decreased GFR at baseline. Plan to resume on dc   Chronic cough -Etiology unclear. Stopped lisinopril in the past without any benefit -Patient is on Flonase in the outpatient setting.  Also takes Tessalon Perles. -Continue Tessalon Perles continue to monitor.   HTN -Continue home lisinopril.   History of recurrent UTIs -Seen by outpatient urology.  Sees Dr.  -Last evaluated 10/2022. -She was placed on Macrobid for recurrent UTIs and has had good symptomatic control.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Skin warm
Clinical narrative: pt experiencing redness on her left arm, as well as hot to the touch. started 9/30/23, afternoon a few hours post vaccination, redness is as big as a hand according to patient, and it raised some concern. Has not tried to do anything for symptom monitoring. recommended ice, or tylenol
Age: 76.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Ear discomfort, Facial pain, Injection site erythema, Injection site swelling
Clinical narrative: Patient states that she received both shots in her right arm and when she woke up the next morning, her right upper arm where she received vaccines from shoulder to elbow was swollen and red.  She also states that her opposite (left) side of her face was hurting and her left ear felt clogged.  This lasted for about 4-5 days then resolved.
Age: 68.0
Sex: M
Vaccine: PNC20
Symptoms: Immediate post-injection reaction, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Patient stated he had a local reaction  right after the vaccination that swollen ,red  and pain at the site of reaction that lasted at least 2 weeks then once that went away the pain persisted. To this day,  he states his arm is still sore and he  went to Dr. for advice but Dr. sent him to as since he got the shot here.
Age: 72.0
Sex: M
Vaccine: RSV, RSV
Symptoms: Hypercoagulation, Inflammation, Ischaemic stroke, Lethargy, Middle cerebral artery stroke
Clinical narrative: Severe Lethargy from day one and arm pain along with achiness. Patient suffered an Ischemic Stroke Left side MCA with two lobes involved on morning of October 21 with normal blood pressure. Cardiologist and Neurologist believe it might be cardio-embolic but patient has no significance of plaque in heart, carotids or brain. Patient had successful maze procedure in 1999. Also suffered a venal subarachnoid hemorrhage in 2018 from coughing from chest cold. Cardiologist did not treat with anticoagulation therapy since hemorrhage. After vaccine patient suffers stroke in  hospitalized and just flew home.  Patient has been very healthy before vaccine administration. This is my husband. I know how bad I feel in my head from the vaccine with sharp stabbing pains and almost like an electric shock and documented my adverse events in writing as well.  The mRNA is causing inflammation that causes a hypercoagulable state. My husband has not had any issues before. Signed wife
Age: 72.0
Sex: M
Vaccine: RSV, RSV
Symptoms: Pain, Pain in extremity
Clinical narrative: Severe Lethargy from day one and arm pain along with achiness. Patient suffered an Ischemic Stroke Left side MCA with two lobes involved on morning of October 21 with normal blood pressure. Cardiologist and Neurologist believe it might be cardio-embolic but patient has no significance of plaque in heart, carotids or brain. Patient had successful maze procedure in 1999. Also suffered a venal subarachnoid hemorrhage in 2018 from coughing from chest cold. Cardiologist did not treat with anticoagulation therapy since hemorrhage. After vaccine patient suffers stroke in  hospitalized and just flew home.  Patient has been very healthy before vaccine administration. This is my husband. I know how bad I feel in my head from the vaccine with sharp stabbing pains and almost like an electric shock and documented my adverse events in writing as well.  The mRNA is causing inflammation that causes a hypercoagulable state. My husband has not had any issues before. Signed wife
Age: 72.0
Sex: M
Vaccine: RSV, RSV
Symptoms: Amnesia, Facial paralysis, Headache, Ischaemic stroke, Lethargy
Clinical narrative: Severe Lethargy from day one and arm pain along with achiness. Patient suffered an Ischemic Stroke Left side MCA with two lobes involved on morning of October 21 with normal blood pressure. Cardiologist and Neurologist believe it might be cardio-embolic but patient has no significance of plaque in heart, carotids or brain. Patient had successful maze procedure in 1999. Also suffered a venal subarachnoid hemorrhage in 2018 from coughing from chest cold. Cardiologist did not treat with anticoagulation therapy since hemorrhage. After vaccine patient suffers stroke in  hospitalized and just flew home.  Patient has been very healthy before vaccine administration. This is my husband. I know how bad I feel in my head from the vaccine with sharp stabbing pains and almost like an electric shock and documented my adverse events in writing as well.  The mRNA is causing inflammation that causes a hypercoagulable state. My husband has not had any issues before. Signed wife
Age: 72.0
Sex: M
Vaccine: RSV, RSV
Symptoms: Middle cerebral artery stroke, Vertigo
Clinical narrative: Severe Lethargy from day one and arm pain along with achiness. Patient suffered an Ischemic Stroke Left side MCA with two lobes involved on morning of October 21 with normal blood pressure. Cardiologist and Neurologist believe it might be cardio-embolic but patient has no significance of plaque in heart, carotids or brain. Patient had successful maze procedure in 1999. Also suffered a venal subarachnoid hemorrhage in 2018 from coughing from chest cold. Cardiologist did not treat with anticoagulation therapy since hemorrhage. After vaccine patient suffers stroke in  hospitalized and just flew home.  Patient has been very healthy before vaccine administration. This is my husband. I know how bad I feel in my head from the vaccine with sharp stabbing pains and almost like an electric shock and documented my adverse events in writing as well.  The mRNA is causing inflammation that causes a hypercoagulable state. My husband has not had any issues before. Signed wife
Age: 22.0
Sex: F
Vaccine: FLUR4
Symptoms: Dizziness
Clinical narrative: After administering the vaccine the patient stated she felt a little light headed and sat down on the floor.  Then she slumped side ways into a fetal position and stated she felt like she was going to pass out.  The patient never lost consciousness and rested in the fetal position for about 5 minutes.  Then sat up and had some cracker and Gatorade.  The patient felt better, waited in the waiting room chair for another 5 to 10 minutes then left.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV9, MNQ
Symptoms: Syncope
Clinical narrative: After patient received third vaccine, patient fainted. RN was able to keep patient on exam table during fainting episode. After 15 seconds, patient became A&O x5. Patient was given juice and sugary snack. Patient's blood pressure at 11:14am, 2 minutes after fainting episode was 114/69. Patient remained in office for 15 minutes for observation post-fainting episode. Patient's blood pressure at 11:30am, prior to patient leaving, was 124/67. Pt stated she felt well and stated that she was able to stand. Pt walked out of clinic with sister without difficulty.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aortic aneurysm, Aortic aneurysm repair, Aortic dilatation, Arterial repair
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine, Blood culture negative, Blood lactic acid, Body temperature increased, Brain natriuretic peptide increased
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19 pneumonia, Chronic kidney disease, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Diabetes mellitus inadequate control, Diarrhoea, Dyspnoea, Fibrin D dimer increased
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count abnormal, Glycosylated haemoglobin normal, Headache, Lung opacity, Nausea
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Pneumonia, Pulmonary mass, Sepsis, Troponin normal
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting, White blood cell count decreased
Clinical narrative: Patient is a 68 y.o. male patient of MD with history of Cancer, GERD, depression, HTn, OSA, COPD presented to Hospital with shortness of breath  .   Sepsis, Acute hypoxic respiratory failure d/t COVID-19 pneumonia, COPD exacerbation  OSA  Elevated D dimer P/w SOB, HA, N/V/D.vaccination unknown  on arrival temp 99 increased to 101.5 , HR 10, RR 26, BP 133/61, satting 88% on RA< increased to 93% 2L Initial CBC w WBC 4., repeat LA 1.1 Troponin normal, BNP 641, D Dimer 1.0, CRP 43.8 CT Chest : no PE, emphysema and fibrosis, nodular opacity in RML possible round pneumonia , cannot exclude nodule   Solumedrol given in ER  Blood Cx NGTD   Decadron 6mg daily for 10 days  Continue cefdinir, Zithromax and home inhalers Follow up with pcp   Renal Cell Carcinoma S/p partial nephrectomy in 201  Follows with urology at hospital    AAA  S/p repair endovascualr infrarenal aorta/iliac artery at hospital  On admit CT has dilated of the aortic arch 3.6 cm, descending thoracic aorta 3 cm Will need vascular follow up    CKD stage 3 a Creatinine over last year 1.3-1.46 At baseline on admit, 1.35   Nicotine dependence Current 1 PPD smoker Discussed and encouraged smoking cessation, >3min total time spent   Nodular opacity in lung Most Likely pneumonia, follow up CT in 3 months recommended.  Alternatively PET-CT could also be considered.   T2DM - uncontrolled A1C: 7.8 continue oral meds F/u with pcp
Age: 9.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia
Clinical narrative: 12/24/2021 - noticable loss of hair around hairline on forhead January 2022 - quarter size of hairloss on back of head June 2022 - 95% bald
Age: 9.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alopecia, SARS-CoV-2 test
Clinical narrative: 12/24/2021 - noticable loss of hair around hairline on forhead January 2022 - quarter size of hairloss on back of head June 2022 - 95% bald